Article
Simultaneous fluorescence immunophenotyping and Her-2/neu genotyping (FICTION) in breast carcinoma candidates to target therapy.
Applied immunohistochemistry & molecular morphology : AIMM - 1 Jul 2012
Gatta Luisa Benerini, Incardona Paolo, Cadei Moris, Grigolato Piergiovanni, Simoncelli Sabrina, Balzarini Piera
Abstract excerpt
The study of proto-oncogene Her-2/neu using the fluorescence in situ hybridization (FISH) technique in routinely paraffin-embedded formalin-fixed tissue has become commonplace over the past decade and mandatory among invasive breast cancer expressing a score 2+ by immunohistochemical analysis of c-erbB2 protein. The patient's eligibility for treatment with the biological drug trastuzumab/herceptin is based on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
